ANEUVYSION MULTICOLOR DNA PROBE KIT

ANEUVYSION background color
ANEUVYSION background color
ANEUVYSION background color

The AneuVysion Multicolor DNA Probe Kit (Vysis CEP 18/X/Y - alpha satellite / LSI 13/21), which utilizes fluorescence in situ hybridization (FISH) technology applied to uncultured or cultured amniocytes, provides detection of trisomies 13, 18, and 21 (Down syndrome) and sex chromosome aneusomies in as little as 24 hours.

For In Vitro Diagnostic Use

Product is not available where CE certification is required

Together, trisomies 13, 18, and 21 (Patau’s, Edwards and Down syndrome) and sex chromosome aneusomies account for 57% of all abnormalities identified at the time of amniocentesis, and 85-90% of clinically significant chromosomal abnormalities detected in live-born infants. Review of AneuVysion testing of over 29,000 amniotic fluid samples has found that the test is 99.9% specific with 99.6% sensitivity for the detection of trisomies 13, 18, 21, Klinefelter and Turner syndrome, and  aneusomies of X and Y.

 

AneuVysion Kit Contents

Each AneuVysion kit includes:

  • CEP 18/X/Y and LSI 13/21 probes packaged in two probe mixtures 
  • Wash reagents NP-40 and 20X SSC
  • DAPI II counterstain
  • Package insert with instructions for use

CEP 18/X/Y and LSI 13/21 are pre-mixed with Blocking DNA and Hybridization Buffer.

The AneuVysion (Vysis CEP 18, X, Y-alpha satellite, LSI 13 and 21) Multicolor Probe Panel is intended to use CEP 18/X/Y probe to detect alpha satellite sequences in the centromere regions of chromosomes 18, X, and Y, and LSI 13/21 probe to detect the 13q14 region and the 21q22.13 to 21q22.2 region. The AneuVysion kit is indicated for identifying and enumerating chromosomes 13, 18, 21, X, and Y via FISH in metaphase cells and interphase nuclei obtained from amniotic fluid in subjects with presumed high risk pregnancies. It is not intended to be used as a stand alone assay for making clinical decisions. FISH results are intended to be used as an aid in the diagnosis of numerical abnormalities of chromosomes 13, 18, 21, X and/or Y in conjunction with other information currently used in prenatal diagnosis, consistent with professional standards of practice.1 This device is intended for use only with amniocyte cells; it is not intended for and has not been validated for use with other test matrices. This FISH assay will not detect the presence of structural chromosome abnormalities that can also result in birth defects. This FISH assay will be performed in cytogenetics laboratories.

Explore

Alinity mp

Learn more about how the Alinity mp uses automation to help improve lab productivity.  

simpli-COLLECT STI Collection Kits

Find out how the simpli-COLLECT STI Collection Kits promote self-care, extend accessibility, and make high-quality STI testing more convenient and reachable.

Alinity m HR HPV Assay

Discover the complete HPV solution that supports your laboratory's testing needs.

REFERENCES
  1. American College of Medical Genetics. Technical and clinical assessment of fluorescence in situ hybridization: an ACMG/ASHG position statement. I. Technical considerations. Genet Med. 2000;2(6):356-361.